The UK's premier summit dedicated to infection prevention, sterilization and decontamination excellence — built by practitioners, for practitioners.
BioShield 2026 is a premier two-day international forum dedicated to advancing best practices, innovation, and strategic leadership in infection control, sterilization, and decontamination within healthcare settings. Conceptualised and produced by Convolign Business Consulting — a global B2B conference organiser delivering high-impact healthcare forums across Europe. Learn more about the summit →
Tackling the £1B+ annual NHS burden of HAIs through evidence-based prevention programmes, surveillance tools, and real-world case studies from leading UK Trusts.
Integrating IPC and antimicrobial stewardship strategies to combat the growing threat of drug-resistant organisms across acute and community care settings.
Deep-dive into CSSD/SSD operations, endoscope reprocessing, low-temperature sterilization, traceability, and sustainability in decontamination workflows.
Exploring automation, AI-powered surveillance, digital traceability systems, and next-generation disinfection technologies reshaping infection prevention.
The role of air, water, surfaces, and facility design in infection transmission — and how smart environmental strategies reduce clinical risk.
Balancing safety, cost, and the NHS Net Zero agenda — practical frameworks for reducing the environmental footprint of decontamination operations.
BioShield 2026 brings together the senior professionals who lead infection prevention and sterile services strategy across the UK and Europe.
Infection Prevention & Control nurses, doctors, and department heads from NHS and private healthcare
Decontamination and sterile services leaders responsible for CSSD operations, compliance, and quality
Clinical microbiologists, infectious disease physicians, and diagnostic lab leaders
Clinical services managers overseeing surgical, endoscopy, and perioperative decontamination workflows
Engineers responsible for decontamination equipment, maintenance, and built environment safety
Hospital quality directors, risk managers, and patient safety leads with IPC accountability
Healthcare executives and directors responsible for IPC strategy, investment, and governance
Medical device, sterilization, and disinfection companies seeking to connect with procurement decision-makers
Policymakers, UKHSA representatives, academic researchers, and NHS England advisors
The only event dedicated to both infection prevention and sterile services — no dilution, no noise.
Every session curated by clinical experts. Vendor-neutral. Agenda-first. Real-world applicability guaranteed.
Connect with IPC Leads, CSSD Managers, and NHS Directors shaping infection control strategy.
HTM standards, NHS Net Zero, EU MDR — expert-led regulatory sessions keep you ahead of the curve.
Accredited CPD sessions and case studies you can implement the week you return to your organisation.
BioShield 2026 is bringing together 25+ world-class speakers from infection prevention, sterile services, clinical microbiology, and healthcare leadership.

Director of Governance
Institute of Decontamination Sciences
Specialty doctor
NHS EnglandSpeaker programme curated by Convolign Business Consulting · Enquire about speaking opportunities →
Two intensive days — Day 1 focused on infection prevention and control, Day 2 on sterilization, decontamination, and reprocessing excellence.
The infection prevention and sterile services landscape represents one of the fastest-growing segments in UK and global healthcare.
Annual market size, growing with NHS capital investment in CSSD infrastructure and HTM compliance upgrades
Healthcare-associated infections affect millions annually, costing European health systems billions in treatment costs
Growing at 8.2% CAGR, driven by regulatory compliance requirements, AMR awareness, and post-pandemic IPC investment
Growing at 6.5% CAGR as hospitals modernise CSSD departments and adopt advanced low-temperature sterilization technologies
Planned capital expenditure across European hospital systems on decontamination infrastructure and digitisation
Antimicrobial resistance listed as a top 10 global public health threat — driving urgent IPC and stewardship investment
FutureDx Summit 2026 is a premier international conference focused on infectious diseases and molecular diagnostics — running alongside BioShield 2026 at the same London venue. BioShield delegates can access select FutureDx sessions, expanding exposure to diagnostics innovation, AMR detection technologies, and public health strategy.
Join 120+ senior infection prevention and sterile services professionals. Three pass types from £695.
View Registration & PassesShowcase your brand to IPC Leads, CSSD Managers, and NHS decision-makers. Five tiers available.
View Sponsorship PackagesBioShield 2026 takes place at a premier central London venue — accessible by underground, rail, and all major London airports. Preferred hotel rates at nearby accommodation provided to all registered delegates and sponsors.
Our team responds within 24 business hours. Reach us directly or visit the Contact page for the full enquiry form.